Harvest’s AxelaCare acquires ARC Infusion

AxelaCare Health Solutions, a provider of specialty home infusion services, has acquired Los Angeles-based ARC Infusion, a privately owned home infusion services company, from founder Rose Lee. Terms of the transaction were not disclosed. AxelaCare is a portfolio company of Harvest Partners.


AxelaCare Health Solutions, a leading provider of specialty home infusion services, announced today that it has acquired Los Angeles-based ARC Infusion Corp. Inc. (“ARC Infusion”), a privately owned home infusion services company, from founder Rose Lee. Terms of the transaction were not disclosed.

The acquisition will bring the number of AxelaCare pharmacies to 15, including four pharmacies in California, and expand the company’s service areas in Southern California. AxelaCare’s growing national coverage includes facilities in Arizona, California, Colorado, Kansas, Louisiana, Maryland, Nebraska, New Mexico, Oklahoma, Oregon, and Pennsylvania. Current ARC management and staff are expected to remain with the company.

“ARC Infusion is a great addition for us as it builds our presence in California in both the IG (immunoglobulin) and acute home infusion markets,” said Ted Kramm, CEO of AxelaCare. “We are continuing to actively pursue acquisitions in California as well as other states to increase our geographic and product line diversification.”

Acute home infusion covers a broad spectrum of therapies for patients discharged from hospitals and receiving infusion therapy at home. These include intravenous antibiotics, hydration, antiemetic, nutrition, inotropes, and other acute and chronic therapies delivered intravenously under a nurse’s care. Home based use of these therapies shortens hospital stays, saves healthcare dollars, and improves patient recovery, while reducing costly hospital readmissions.

“In this competitive and changing healthcare environment, leading managed care players are requiring their partners to provide national coverage, regional presence, and product diversity. AxelaCare is raising the bar further by delivering great patient care and innovative outcomes technology,” added Joe Zavalishin, Executive Vice President, Strategic Contracting & Payer Relations at AxelaCare.

# # #

About ARC Infusion
ARC Infusion is a regional, privately owned corporation that provides pharmaceutical services to patients in Los Angeles, Orange Country, and the Inland Empire. Licensed by the California State Board of Pharmacy, ARC Infusion specializes in providing infusion and injectable medications and supplies to patients in their homes.

About AxelaCare Health Solutions
Based in Lenexa, Kansas, AxelaCare is a leading provider of specialized immune globulin (IgG) therapy and other intravenous home infusion therapies. Founded by a nurse and pharmacist team and focused on patient care first, AxelaCare is the market leader in supporting outcomes research for immune therapy and has created the industry’s first electronic patient outcomes assessment technology, CareExchange®. AxelaCare has experienced tremendous growth, added top-flight management and employee teams in nursing, patient advocacy, pharmacy, sales and customer service. AxelaCare is actively acquiring regional and local infusion pharmacies to grow its local market presence and nationwide coverage, infusion therapy portfolio, and implement its advanced outcomes technology.